HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cerebrospinal fluid diversion procedures in pseudotumor cerebri.

Abstract
We reviewed the efficacy of CSF diversion for pseudotumor cerebri (PTC) in patients from six different institutions. Thirty-seven patients underwent a total of 73 lumboperitoneal shunts and nine ventricular shunts. Only 14 patients remained "cured" after a single surgical procedure. The average time between shunt insertion and shunt replacement was 9 months, although 64% of shunts lasted less than 6 months. Shunt failure (55%) and low-pressure headaches (21%) were the most common causes for reoperation. The vision of most patients improved (13) or stabilized (13) postoperatively. However, three who had initially improved subsequently lost vision. Six had a postoperative decrease in vision. Two patients improved in one eye but worsened postoperatively in the other. Four lost vision despite apparently adequate shunt function. Shunt failure with relapse of PTC occurred as late as 7 years after insertion. CSF diversion procedures have a significant failure rate as well as a high frequency of side effects.
AuthorsM L Rosenberg, J J Corbett, C Smith, J Goodwin, R Sergott, P Savino, N Schatz
JournalNeurology (Neurology) Vol. 43 Issue 6 Pg. 1071-2 (Jun 1993) ISSN: 0028-3878 [Print] United States
PMID8170543 (Publication Type: Journal Article, Multicenter Study)
Topics
  • Cerebrospinal Fluid Shunts (adverse effects)
  • Follow-Up Studies
  • Headache (etiology)
  • Humans
  • Peritoneum
  • Postoperative Complications
  • Pseudotumor Cerebri (complications, surgery)
  • Reoperation
  • Treatment Outcome
  • Ventriculoperitoneal Shunt
  • Vision Disorders (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: